Good for Celebrants, Better for Colon Cancer Patients

Dr. John Marshall discusses a study that found regular aspirin use to increase survival in CRC patients, especially those with PIK3CA mutation. But should all CRC patients take it, and at what dose?

Source: Medscape Pathology and Laboratory Medicine Podcast - January 10, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts